Yi-Xin Wang

Yi-Xin Wang

President chez Crown Bioscience North Carolina

Health Technology
Commercial Services
Consumer Services

Profil

Yi-Xin Wang is currently employed as the SVP-Cardiovascular & Metabolic Diseases Research at Crown Bioscience, Inc. and as the President at Crown Bioscience North Carolina.
Previously, Dr. Wang held positions such as Pharmacology Director at Arête Therapeutics, Inc., President & Director at PreClinOmics, Inc., and Principal at Berlex, Inc., Bayer Schering Pharma AG, Hoffman-LaRoche F & Co. AG, Bayer HealthCare Pharmaceuticals, Inc., and GlaxoSmithKline LLC.
Dr. Wang also worked as a Senior Scientist at Roche Pharmaceuticals, Inc. and as a Professor and Assistant Professor at the University of Tennessee.
Dr. Wang received graduate and doctorate degrees from Shanghai Jiao Tong University.

Postes actifs de Yi-Xin Wang

SociétésPosteDébut
Corporate Officer/Principal 01/07/2010
President -
Tous les postes actifs de Yi-Xin Wang

Anciens postes connus de Yi-Xin Wang

SociétésPosteFin
Corporate Officer/Principal 01/01/2009
Corporate Officer/Principal 01/01/2008
BAYER AG Corporate Officer/Principal 01/01/2008
University of Tennessee Corporate Officer/Principal 01/01/1996
President -
Voir l'expérience en détail de Yi-Xin Wang

Formation de Yi-Xin Wang

Shanghai Jiao Tong University Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Yi-Xin Wang

Relations

99

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
BAYER AG

Health Technology

Entreprise privées10

Health Technology

Bayer Schering Pharma AG

Health Technology

Commercial Services

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Yi-Xin Wang
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT